Health
Researchers inch closer to more precise treatment for patients with type 1 diabetes – Mental Daily
The new findings could prove to be a major step towards ensuring that patients with diabetes receive the exact right amount of insulin.
A coalition of experts at the University of Copenhagen and the biotech company Gubra have unveiled an insulin molecule capable of self-regulating blood sugar for patients with type 1 diabetes.
The study appeared in Chemistry – A European Journal.
The new findings could prove to be a major step towards ensuring that patients with diabetes receive the exact right amount of insulin.
The insulin molecule was tested on rodents first and demonstrated efficiency for detecting blood sugar is in the body,…
-
Business18 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News15 hours agoTips to improve engagement – Proctor
-
Noosa News17 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General20 hours ago‘Get on with it’: next move key with rate cut baked in